123 related articles for article (PubMed ID: 6343491)
1. An enzyme-linked immunosorbent assay for antistriational antibodies associated with myasthenia gravis and thymoma: comparison with indirect immunofluorescence.
Carrano JA; Swanson NR; Dawkins RL
J Immunol Methods; 1983 May; 59(3):301-14. PubMed ID: 6343491
[TBL] [Abstract][Full Text] [Related]
2. The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis.
Peers J; McDonald BL; Dawkins RL
Clin Exp Immunol; 1977 Jan; 27(1):66-73. PubMed ID: 321160
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent assay for detection of antibodies to extractable muscle antigens in myasthenia gravis.
Viana VS; Bueno C; Marchiori PE; Oliveira RM; Assis JL; Scaff M; Cossermelli W
Acta Neurol Scand; 1986 Jun; 73(6):599-601. PubMed ID: 3751500
[TBL] [Abstract][Full Text] [Related]
4. An enzyme-linked immunosorbent assay for antibodies against acid soluble skeletal muscle antigen in myasthenia gravis.
Annamma M; Sarada C; Radhakrishnan VV
Acta Neurol Scand; 1999 Sep; 100(3):175-7. PubMed ID: 10478581
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diagnostic value for the detection of thymoma.
Kuks JB; Limburg PC; Horst G; Dijksterhuis J; Oosterhuis HJ
J Neurol Sci; 1993 Nov; 119(2):183-8. PubMed ID: 8277333
[TBL] [Abstract][Full Text] [Related]
6. Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow.
Cikes N; Momoi MY; Williams CL; Howard FM; Hoagland HC; Whittingham S; Lennon VA
Mayo Clin Proc; 1988 May; 63(5):474-81. PubMed ID: 3283472
[TBL] [Abstract][Full Text] [Related]
7. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
Smith CI; Aarli JA; Hammarström L; Persson MA
Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to skeletal muscle in myasthenia gravis. Part 2. Prevalence in non-thymoma patients.
Kuks JB; Limburg PC; Horst G; Oosterhuis HJ
J Neurol Sci; 1993 Dec; 120(1):78-81. PubMed ID: 8289082
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups.
Hofstad H; Ulvestad E; Gilhus NE; Matre R; Aarli JA
Acta Neurol Scand; 1992 Apr; 85(4):233-8. PubMed ID: 1585794
[TBL] [Abstract][Full Text] [Related]
10. An enzyme-linked immunosorbent assay for antibodies against saline-soluble muscle components in myasthenia gravis.
Akazawa S; Furukawa S; Kamo I; Furukawa Y; Satoyoshi E; Hayashi K
J Immunol Methods; 1986 Nov; 94(1-2):161-7. PubMed ID: 3782808
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous thymoma, polymyositis, and serum-autoantibodies to striated muscle in the rodent, subgenus Praomys (Mastomys) natalensis. Similarities to thymoma with myasthenia gravis in man.
Strauss AJ; Snell KC; Duntley BJ; Soban EJ; Stewart HL
Lancet; 1968 May; 1(7552):1126-9. PubMed ID: 4171846
[No Abstract] [Full Text] [Related]
12. Heart muscle antibodies in myasthenia gravis.
Mygland A; Aarli JA; Hofstad H; Gilhus NE
Autoimmunity; 1991; 10(4):263-7. PubMed ID: 1772962
[TBL] [Abstract][Full Text] [Related]
13. Muscle pathology, thymoma, and immunological abnormalities in patients with myasthenia gravis.
Oosterhuis HJ; Bethlem J; Feltkamp TE
J Neurol Neurosurg Psychiatry; 1968 Oct; 31(5):460-3. PubMed ID: 4885252
[No Abstract] [Full Text] [Related]
14. Autoantibodies in D-penicillamine-induced myasthenia gravis: a comparison with idiopathic myasthenia and rheumatoid arthritis.
Morel E; Feuillet-Fieux MN; Vernet-der Garabedian B; Raimond F; D'Anglejan J; Bataille R; Sany J; Bach JF
Clin Immunol Immunopathol; 1991 Mar; 58(3):318-30. PubMed ID: 2001604
[TBL] [Abstract][Full Text] [Related]
15. Serum autoantibodies in myasthenia gravis and thymoma: selective affinity for I-bands of striated muscle as a guide to identification of antigen(s).
Strauss AJ; Kemp PG
J Immunol; 1967 Nov; 99(5):945-53. PubMed ID: 4169038
[No Abstract] [Full Text] [Related]
16. Detection of thymoma in myasthenia gravis.
Keesey J; Bein M; Mink J; Sample F; Sarti D; Mulder D; Herrmann C; Peter JB
Neurology; 1980 Mar; 30(3):233-9. PubMed ID: 7189022
[TBL] [Abstract][Full Text] [Related]
17. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
Mygland A; Aarli JA; Matre R; Gilhus NE
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
[TBL] [Abstract][Full Text] [Related]
18. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
[TBL] [Abstract][Full Text] [Related]
19. HL-A antigens, autoantibody production, and associated diseases in thymoma patients, with and without myasthenia gravis.
Oosterhuis HJ; Feltkamp TE; van Rossum AL; van den Berg-Loonen PM; Nijenhuis LE
Ann N Y Acad Sci; 1976; 274():468-74. PubMed ID: 1085589
[TBL] [Abstract][Full Text] [Related]
20. [Immunofluorescence studies in myasthenia].
Slomkowska H
Neurol Neurochir Pol; 1972; 6(2):205-10. PubMed ID: 4555306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
